SAMANTHA AMENDOLA: Open Payments
NPI 1932707932 · BRIGHTWATERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 14 payments from 9 companies in 2025. Trend: 2023 $477 · 2024 $175 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| PFIZER INC. | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Novo Nordisk Inc | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LEQVIO, ELIQUIS, NEXLETOL, AMVUTTRA, Ozempic, REPATHA, VERQUVO, MOUNJARO.
Industry payments across NY — which companies pay providers there.
